{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:13:43Z","timestamp":1778710423889,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-STaR21jun-0003"],"award-info":[{"award-number":["MOH-STaR21jun-0003"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CG21APR1006"],"award-info":[{"award-number":["CG21APR1006"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CG21APRC006"],"award-info":[{"award-number":["NMRC\/CG21APRC006"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016017","name":"Duke-NUS Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Government of Singapore Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007112","name":"University of Cape Town","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001338","name":"University of Capetown","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009978","name":"The Oppenheimer Memorial Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.lfs.2024.123145","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T02:14:34Z","timestamp":1728699274000},"page":"123145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Interplay between the SAFE and the sphingolipid pathway for cardioprotection"],"prefix":"10.1016","volume":"358","author":[{"given":"Martin","family":"Cour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Pedretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Nduhirabandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Hacking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Frias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek J.","family":"Hausenloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Lecour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.123145_bb0005","article-title":"Global epidemiology of ischemic heart disease: results from the global burden of disease study","volume":"12","author":"Khan","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.lfs.2024.123145_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00395-016-0588-8","article-title":"Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery","volume":"111","author":"Hausenloy","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.lfs.2024.123145_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cvr\/cvp274","article-title":"Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway","volume":"84","author":"Lacerda","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.123145_bb0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4161\/jkst.19754","article-title":"High density lipoprotein\/sphingosine-1-phosphate-induced cardioprotection: role of STAT3 as part of the SAFE pathway","volume":"1","author":"Frias","year":"2012","journal-title":"JAK-STAT"},{"key":"10.1016\/j.lfs.2024.123145_bb0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10557-012-6376-2","article-title":"Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection","volume":"26","author":"Somers","year":"2012","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.lfs.2024.123145_bb0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1600-079X.2010.00853.x","article-title":"Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection","volume":"50","author":"Lamont","year":"2011","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2024.123145_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00395-018-0670-5","article-title":"The SAFE pathway for cardioprotection: is this a promising target?","volume":"113","author":"Hadebe","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.lfs.2024.123145_bb0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00395-021-00898-0","article-title":"Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function","volume":"116","author":"Comit\u00e0","year":"2021","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.lfs.2024.123145_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/cvr\/cvn309","article-title":"Sphingosine kinase regulation and cardioprotection","volume":"82","author":"Karliner","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.123145_bb0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10741-007-9038-x","article-title":"HDL and its sphingosine-1-phosphate content in cardioprotection","volume":"12","author":"Keul","year":"2007","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.lfs.2024.123145_bb0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.coph.2008.11.002","article-title":"Targeting sphingosine-1-phosphate signalling for cardioprotection","volume":"9","author":"Kennedy","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123145_bb0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/jmcc.2002.1533","article-title":"Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection","volume":"34","author":"Lecour","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2024.123145_bb0065","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.CIR.0000143632.06471.93","article-title":"Sphingosine kinase activation mediates ischemic preconditioning in murine heart","volume":"110","author":"Jin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.123145_bb0070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cardiores.2004.06.019","article-title":"Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning","volume":"63","author":"Smith","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.123145_bb0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0008-6363(02)00283-3","article-title":"Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene","volume":"55","author":"Smith","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.123145_bb0080","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1080\/15384047.2015.1078949","article-title":"Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia","volume":"16","author":"LeBlanc","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2024.123145_bb0085","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1582-4934.2008.00332.x","article-title":"The novel adipocytokine visfatin exerts direct cardioprotective effects","volume":"12","author":"Lim","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2024.123145_bb0090","first-page":"74","article-title":"Role of nuclear factor kappa-B in TNF-induced cytoprotection, Cardiovasc","volume":"34","author":"Kelly-Laubscher","year":"2023","journal-title":"J. Afr."},{"key":"10.1016\/j.lfs.2024.123145_bb0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/cvr\/cvn171","article-title":"The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis","volume":"80","author":"Frias","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2024.123145_bb0100","doi-asserted-by":"crossref","first-page":"H841","DOI":"10.1152\/ajpheart.00678.2003","article-title":"Preconditioning protects by inhibiting the mitochondrial permeability transition","volume":"287","author":"Hausenloy","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2024.123145_bb0105","doi-asserted-by":"crossref","unstructured":"J. Kvetny, T. Bomholt, P. Pedersen, L. Wilms, S. Anthonsen, J. Larsen, Thyroid hormone effect on human mitochondria measured by flow cytometry, Scand. J. Clin. Lab. Invest. 69 (2009) 772\u2013776. doi:https:\/\/doi.org\/10.3109\/00365510903154752.","DOI":"10.3109\/00365510903154752"},{"key":"10.1016\/j.lfs.2024.123145_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106436","article-title":"Sphingosine 1-phosphate signaling in ischemia and reperfusion injury","volume":"149","author":"Raza","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.lfs.2024.123145_bb0115","first-page":"22","article-title":"The RISK pathway leading to mitochondria and cardioprotection: how everything started, basic res","volume":"118","author":"Yellon","year":"2023","journal-title":"Cardiol"},{"key":"10.1016\/j.lfs.2024.123145_bb0120","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00395-011-0223-7","article-title":"A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection","volume":"106","author":"Gomez","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.lfs.2024.123145_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00395-023-01003-3","article-title":"Perspective: mitochondrial STAT3 in cardioprotection","volume":"118","author":"Kleinbongard","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.lfs.2024.123145_bb0130","first-page":"318","article-title":"Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury","volume":"12","author":"Vessey","year":"2006","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.lfs.2024.123145_bb0135","doi-asserted-by":"crossref","first-page":"34499","DOI":"10.1074\/jbc.274.48.34499","article-title":"Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells","volume":"274","author":"Xia","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.123145_bb0140","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1074\/jbc.M111423200","article-title":"Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling","volume":"277","author":"Xia","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.123145_bb0145","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nature09128","article-title":"Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2","volume":"465","author":"Alvarez","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.123145_bb0150","doi-asserted-by":"crossref","first-page":"10279","DOI":"10.3748\/wjg.v20.i30.10279","article-title":"STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer","volume":"20","author":"Nguyen","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2024.123145_bb0155","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.neuropharm.2006.11.010","article-title":"Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors","volume":"52","author":"Osinde","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2024.123145_bb0160","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.bbalip.2018.08.015","article-title":"Molecular mechanisms of regulation of sphingosine kinase 1","volume":"1863","author":"Pulkoski-Gross","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.lfs.2024.123145_bb0165","doi-asserted-by":"crossref","first-page":"H2944","DOI":"10.1152\/ajpheart.01331.2006","article-title":"Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury","volume":"292","author":"Means","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2024.123145_bb0170","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/pros.21285","article-title":"HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1\/2 and S1P receptors, and promote cell migration and invasion","volume":"71","author":"Sekine","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.lfs.2024.123145_bb0175","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/eurheartj\/ehq484","article-title":"When are pro-inflammatory cytokines SAFE in heart failure?","volume":"32","author":"Lecour","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2024.123145_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119664","article-title":"Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury","volume":"10","author":"Brulhart-Meynet","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2024.123145_bb0185","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/cvr\/cvab139","article-title":"Extracellular histones are a target in myocardial ischaemia-reperfusion injury","volume":"118","author":"Shah","year":"2022","journal-title":"Cardiovasc. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524007355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524007355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:49:58Z","timestamp":1778708998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524007355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"alternative-id":["S0024320524007355"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123145","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay between the SAFE and the sphingolipid pathway for cardioprotection","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"123145"}}